Related Experiment Video
Updated: Dec 18, 2025

08:53
Using the Droplet Transfer Method to Reliably Prepare Giant Unilamellar Vesicles
Published on: September 19, 2025
984
Vancomycin Loaded Glycerol Monooleate Liquid Crystalline Phases Modified with Surfactants
Spomenka Milak1, Angela Chemelli2, Otto Glatter2
1Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmaceutical Sciences, University of Graz, NAWI Graz, Universitätsplatz 1, 8010 Graz, Austria.
Pharmaceutics
|June 12, 2020
Summary
Polyglycerol ester (PE) and triblock copolymer (TC) modified glycerol monooleate liquid crystalline phases (LCPs) were explored for vancomycin hydrochloride (VHCl) eye delivery. LCPs with 30% PE showed potential for sustained intravitreal VHCl delivery over 48 hours.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Ophthalmic Drug Delivery
Background:
- Glycerol monooleate (MO) liquid crystalline phases (LCPs) are investigated for drug delivery applications.
- Achieving therapeutic concentrations of vancomycin hydrochloride (VHCl) in the eye requires effective delivery systems.
- Polyglycerol ester (PE) and triblock copolymer (TC) are explored as modifiers for MO LCPs.
Purpose of the Study:
- To investigate the influence of PE and TC on MO LCP properties.
- To evaluate the suitability of modified LCPs for topical and intravitreal VHCl delivery.
- To determine the optimal LCP formulation for sustained VHCl release in the eye.
Main Methods:
- Small-angle X-ray scattering (SAXS) to analyze LCP structure.
- Polarized light microscopy (PLM) for structural elucidation.
- In vitro release tests simulating ocular application (topical and intravitreal).
Main Results:
- SAXS analysis revealed PE induced a hexagonal to lamellar phase transition in MO LCP.
- TC induced a difficult-to-identify hexagonal phase transition.
- Modified LCPs exhibited distinct VHCl release profiles compared to controls.
- LCPs formulated with 30% PE demonstrated promising sustained VHCl release over 2880 minutes (48 hours).
Conclusions:
- MO LCPs modified with PE and TC alter their structural properties.
- The formulation of MO LCP with 30% PE is a potential candidate for intravitreal vancomycin hydrochloride delivery.
- This delivery system could facilitate sustained release for extended therapeutic effect in the eye.

